Page last updated: 2024-09-03

cholestyramine resin and Stroke

cholestyramine resin has been researched along with Stroke in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Huang, R; Liang, J; Ren, Y; Wang, H; Wu, Q; Xie, J; Yin, J; Zhang, M; Zhu, J1
Cho, T; Maljaars, J; Ortega-Gutierrez, S; Shaban, A1
Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M1
Birbeck, GL; Jacobs, BS; Kothari, RU; Maddox, K; Mullard, AJ; Reeves, MJ; Stoeckle-Roberts, S; Wehner, S1
Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W1

Reviews

1 review(s) available for cholestyramine resin and Stroke

ArticleYear
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
    Archives of internal medicine, 2003, Mar-24, Volume: 163, Issue:6

    Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome

2003

Trials

1 trial(s) available for cholestyramine resin and Stroke

ArticleYear
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    The American journal of cardiology, 2000, Dec-15, Volume: 86, Issue:12

    Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome

2000

Other Studies

3 other study(ies) available for cholestyramine resin and Stroke

ArticleYear
Cholestyramine resin administration alleviated cerebral ischemic injury in obese mice by improving gut dysbiosis and modulating the bile acid profile.
    Experimental neurology, 2023, Volume: 359

    Topics: Animals; Bile Acids and Salts; Brain Injuries; Cholestyramine Resin; Chromatography, Liquid; Dysbiosis; Mice; Mice, Obese; Neuroprotective Agents; Obesity; Stroke; Tandem Mass Spectrometry

2023
Q Fever, CNS Vasculitis, and Stroke: A Case Report.
    The American journal of medicine, 2020, Volume: 133, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Arthritis, Rheumatoid; Cholestyramine Resin; Humans; Leflunomide; Male; Q Fever; Stroke; Vasculitis, Central Nervous System

2020
Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry.
    Stroke, 2006, Volume: 37, Issue:1

    Topics: Aged; Anticoagulants; Cholestyramine Resin; Clofibric Acid; Female; Hospital Records; Hospitalization; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Ischemic Attack, Transient; Lipids; Male; Middle Aged; Models, Statistical; Niacin; Registries; Risk Factors; Stroke

2006